Lineage Cell Therapeutics, Inc. (TLV:LCTX)
Israel
· Delayed Price · Currency is ILS · Price in ILA 363.50
+7.00 (1.96%)
Jun 26, 2025, 5:24 PM IDT
Lineage Cell Therapeutics Market Cap
Lineage Cell Therapeutics has a market cap or net worth of 746.43 million as of June 27, 2025. Its market cap has increased by 14.10% in one year.
Market Cap
746.43M
Enterprise Value
586.99M
Revenue
35.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
363.50
Market Cap Chart
Since May 1, 1992, Lineage Cell Therapeutics's market cap has increased from 49.45M to 746.43M, an increase of 1,409.47%. That is a compound annual growth rate of 8.53%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 66.64B |
| Danel (Adir Yeoshua) | 2.80B |
| Kamada | 1.53B |
| Bait Bakfar | 1.06B |
| BrainsWay | 801.90M |
| Novolog (Pharm-Up 1966) | 722.84M |
| Ilex Medical | 719.95M |
| SofWave Medical | 713.46M |